HRC Ledger
Opportunity

Brand Name - Dectomax (Doramectin) 500mL Injectable Solution

Response due

October 30, 2026

Agency
Mrpbs Minneapolis Mn
Estimated value
Not stated
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation. Quotations are being requested and a separate written solicitation will not be issued. Solicitation number 12639527Q0009 is issued as a Request for Quotation (RFQ) for 2400 bottles of Dectomax 500 ml Injectable solution. This acquisition is set-aside for small business concerns. The applicable North American Industry Classification Standard Code is 325414 The small business size standard is 1,250 employees This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency.

Key dates

Posted
October 19, 2026
Response due
October 30, 2026

Who is this buyer

Mrpbs Minneapolis Mn

Organization

MRPBS MINNEAPOLIS MN

Buying history

  • Records44 total
  • Opportunities / awards3 / 7
  • Value range$29,775 – $190,000
  • ActiveJuly 16, 2026 – October 20, 2026

What they buy

  • Clinical (25)
  • Administrative (18)
  • Insurance (1)

Set-asides used

  • Small Business Set Aside - Total (26)
  • No Set aside used (11)

Who holds their work today

  1. INGENESIS INC1 win · $190,000 · last December 4, 2025
  2. MCFARLAND CLINIC PC1 win · $36,366 · last October 16, 2020

Also open from this buyer

View source document →

Source link on sam.gov.

Source record

Buyer type
Federal
Jurisdiction
Federal (US)
Category
Clinical
Set-aside
Small Business Set Aside - Total
NAICS
325414
PSC
6509